Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Says Brett Mitchell and Nativ Segev, will step down from the board, reflecting the changing direction of the company as it moves away from the medicinal cannabis sector toward a more pharma-focused business strategy. Stephen Parker, currently non-executive director, will replace Mitchell as interim non-executive chair. A new Australian non-executive director will also be appointed. Appoints Oberon Capital as joint broker in the UK with immediate effect alongside Peterhouse Capital.
Current stock price: 0.38 pence, up 0.5% in London on Tuesday
12-month change: down 65%
Copyright 2023 Alliance News Ltd. All Rights Reserved.